文献速递产科母胎医学

围受孕期咖啡因摄入与不良妊娠结局:nuMoM2b队列研究结果

Periconceptual Caffeine Intake and Adverse Pregnancy Outcomes: Results From the nuMoM2b Cohort.
PubMed 文献 · BJOG · 2025-09-23

该研究为nuMoM2b前瞻性队列的二次分析,纳入7345例活产或>20周妊娠丢失的孕妇,评估受孕前三个月自我报告的咖啡因摄入与不良妊娠结局复合指标的关系。高摄入(≥200 mg/天)者841例(11.4%),发生不良妊娠结局2168例(29.5%)。调整混杂因素后,高摄入与不良妊娠结局风险升高无关(aOR 0.99,95% CI 0.84-1.16),咖啡因摄入每增加50 mg亦未发现不良妊娠结局风险显著升高。

要点

  • 围受孕期高咖啡因摄入(≥200 mg/天)与不良妊娠结局复合指标风险升高无关(aOR 0.99,95% CI 0.84-1.16)。
  • 高咖啡因摄入与任何单一不良妊娠结局亦无关。
  • 咖啡因摄入每增加50 mg,未发现不良妊娠结局风险显著升高。

核心结论

  • 围受孕期评估的高咖啡因摄入与不良妊娠结局风险无关。

研究设计与样本

  • nuMoM2b为前瞻性收集的队列,本研究为其二次分析。
  • 分析纳入7345例活产或>20周妊娠丢失的孕妇。
  • 咖啡因摄入通过自我报告的食物频率问卷评估,反映首次产检前三个月的摄入情况。
  • 高咖啡因摄入定义为≥200 mg/天。
  • 采用logistic模型评估高摄入与不良妊娠结局的关联,并调整混杂因素。

主要发现

  • 队列中位每日咖啡因摄入量为63.28 mg/天。
  • 高摄入者841例(11.4%),发生不良妊娠结局者2168例(29.5%)。
  • 调整混杂因素后,高摄入与不良妊娠结局 odds 升高无关(aOR 0.99,95% CI 0.84-1.16)。
  • 高摄入与任何单一不良妊娠结局亦无关。
  • 咖啡因摄入每增加50 mg,未发现不良妊娠结局 odds 显著升高。

关键数值与推荐

  • 高咖啡因摄入定义为≥200 mg/天。
  • 不良妊娠结局定义为>20周妊娠宫内胎死、妊娠期高血压疾病、早产和小于胎龄儿复合指标。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究探索生物标志物和儿童期纵向结局,以阐明摄入方面的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the association of self-assessed caffeine consumption with adverse pregnancy outcomes (APO). DESIGN: Secondary analysis of births in the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be (nuMoM2b). Caffeine intake was assessed by the self-reported Food Frequency Questionnaire reflecting consumption in the three months prior to the first trimester visit. SETTING: nuMoM2b was a prospectively collected cohort. POPULATION: This is a large US-based cohort of pregnant patients. METHODS: High caffeine intake was defined as ≥ 200 mg/day. Logistic models assessed associations between high intake and APO, adjusted for confounders. We also grouped caffeine intake in 50 mg increments and tested whether increased consumption was associated with increased odds of APO. MAIN OUTCOME MEASURES: APO were defined as a composite of intrauterine foetal demise > 20 weeks' gestation, hypertensive disorders of pregnancy, preterm birth and small for gestational age infant. RESULTS: The primary analysis included 7345 participants with live births or pregnancy loss > 20 weeks' gestation, for whom the median daily caffeine intake was 63.28 mg/day. 841 (11.4%) of patients had high intake and 2168 (29.5%) had an APO. When adjusted for confounders, high intake was not associated with increased odds of APO (aOR 0.99, 95% CI 0.84-1.16), nor was it associated with any individual APO. We found no significant increased odds of APO per 50 mg increase in caffeine intake. CONCLUSIONS: High caffeine intake assessed in the periconceptual period was not associated with the risk of APO. Further research exploring biomarkers and longitudinal childhood outcomes is needed to clarify limitations with regard to intake.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Ruderman RS, Freedman AA, Suresh SC, et al. Periconceptual Caffeine Intake and Adverse Pregnancy Outcomes: Results From the nuMoM2b Cohort. BJOG. 2025. PMID: 40987719. doi:10.1111/1471-0528.70018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。